Cargando…

Involved-field radiotherapy in limited-stage small-cell lung cancer

Detalles Bibliográficos
Autores principales:	Chien, C-R, Yu, C-J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360303/ https://www.ncbi.nlm.nih.gov/pubmed/17595661 http://dx.doi.org/10.1038/sj.bjc.6603862

Ejemplares similares

Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses—reply
por: Hu, Xiao, et al.
Publicado: (2020)

Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?
por: Manapov, Farkhad, et al.
Publicado: (2013)

Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer
por: Belderbos, J, et al.
Publicado: (2007)

Adjuvant therapies for resected limited-stage small cell lung cancer
por: Lampridis, Savvas
Publicado: (2021)

Comment on “What is the effect of tumor diameter, lymph node metastases, and maximum standardized uptake value on prognosis in limited-stage small cell lung cancer?”
por: Yu, Hongyan
Publicado: (2023)

Palliative thoracic radiotherapy dose, non-small cell lung cancer with oligometastases and prognosis
por: Ampil, Federico L., et al.
Publicado: (2011)

Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
por: Baas, P, et al.
Publicado: (2006)

Radiotherapy for early stage favourable breast cancers
por: Buchholz, T A, et al.
Publicado: (2002)

Stereotactic ablative radiotherapy for inoperable T1‐2N0M0 small‐cell lung cancer
por: Tang, Hui, et al.
Publicado: (2022)

Radiotherapy tumor volume for limited-stage small cell lung cancer: less is more
por: Levy, Antonin, et al.
Publicado: (2020)

In regards to Chu et al.: Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer
por: Käsmann, Lukas, et al.
Publicado: (2020)

Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis
por: de Bessa, Camila Martins, et al.
Publicado: (2022)

The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer
por: Lee, Kyoung Ju, et al.
Publicado: (2013)

Hypofractionated vs. standard radiotherapy for locally advanced limited-stage small cell lung cancer
por: Saeed, Nadia A., et al.
Publicado: (2022)

Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)

Role of adjuvant treatment in stage IB non-small cell lung carcinoma
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer
por: Huang, Chengliang, et al.
Publicado: (2020)

Extremely elevated serum procalcitonin concentration in a patient with stage IV non-small cell lung cancer
por: Stando, Rafał, et al.
Publicado: (2023)

Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer
por: Abe, Takanori, et al.
Publicado: (2021)

Tumor‐infiltrating CD8(+) T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited‐stage small cell esophageal carcinoma
por: Zhang, Zhihui, et al.
Publicado: (2021)

Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer
por: Zhang, Jing, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy (SBRT) in Very Limited-Stage Small Cell Lung Cancer (VLS-SCLC)
por: Mercier, Stéphanie L., et al.
Publicado: (2022)

Feasibility of Fewer Fraction Palliative Radiotherapy in Resource-Limited Setting
por: Dulal, Soniya, et al.
Publicado: (2020)

＜Editors’ Choice＞ Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experience
por: Suzuki, Gen, et al.
Publicado: (2022)

Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer
por: Han, Dan, et al.
Publicado: (2015)

Comments on “dynamic (18)F‐FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non‐small cell lung cancer”
por: Wang, Shan‐Ying, et al.
Publicado: (2022)

Surgery for limited stage small cell lung cancer
por: Gergen, Anna K., et al.
Publicado: (2020)

Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer
por: Schlick, Brian, et al.
Publicado: (2022)

Merkel cell polyomavirus and non-small cell lung cancer
por: Shuda, M, et al.
Publicado: (2013)

miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients
por: Rodríguez-Antolín, Carlos, et al.
Publicado: (2019)

NRF2-pathway mutations predict radioresistance in non-small cell lung cancer
por: Kinslow, Connor J., et al.
Publicado: (2022)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

Effects of thoracic radiotherapy timing and duration on progression‐free survival in limited‐stage small cell lung cancer
por: Zhao, Shen, et al.
Publicado: (2018)

Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?
por: Barros, José Máximo, et al.
Publicado: (2021)

Relationship between obstructive lung disease and non-small cell lung cancer
por: Akamine, Takaki, et al.
Publicado: (2020)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

Reply: K-Ras: a prognostic factor for survival in non-small cell lung cancer
por: Mascaux, C
Publicado: (2006)

Response to: Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model
por: Jiang, Lisha, et al.
Publicado: (2021)

Consolidative thoracic radiotherapy for extensive stage small cell lung cancer
por: Zhang, Xiaoli, et al.
Publicado: (2017)

Letter to the Editor Regarding “The Effect of Hippocampal Avoidance Whole Brain Radiotherapy on the Preservation of Long-Term Neurocognitive Function in Non-Small Cell Lung Cancer Patients with Brain Metastasis”
por: Pezzulla, Donato, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rm05t6ec9nil2bef5u46vhser7